(Q38295181)

1 September 2017

1 reference

title

PYY3-36: Beyond food intake (English)

1 reference

1 September 2017

3

Wolfgang Langhans

1 reference

1 September 2017

2

Stephen C Woods

1 reference

1 September 2017

Ulrike Stadlbauer

1

1 reference

1 September 2017

Urs Meyer

series ordinal

4

1 reference

1 September 2017

publication date

16 December 2014

1 reference

Frontiers in Neuroendocrinology

1 September 2017

published in

1 reference

1 September 2017

volume

38

1 reference

1 September 2017

page(s)

1-11

1 reference

Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Neuropeptide Y induced modulation of dopamine synthesis in the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Human distribution and release of a putative new gut hormone, peptide YY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Working memory: looking back and looking forward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Hypothalamic Y2 receptors regulate bone formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Psychobiology of novelty seeking and drug seeking behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Gut hormone PYY(3-36) physiologically inhibits food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Inhibition of food intake in obese subjects by peptide YY3-36

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Critical role for peptide YY in protein-mediated satiation and body-weight regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Novelty seeking, incentive salience and acquisition of cocaine self-administration in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The endocrinology of food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The debate over dopamine's role in reward: the case for incentive salience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Dissecting components of reward: 'liking', 'wanting', and learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Metabolic and hedonic drives in the neural control of appetite: who is the boss?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Food reward, hyperphagia, and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Late Prenatal Immune Activation in Mice Leads to Behavioral and Neurochemical Abnormalities Relevant to the Negative Symptoms of Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Dopamine neuron systems in the brain: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The HR/LR model: Further evidence as an animal model of sensation seeking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

PYY transgenic mice are protected against diet-induced and genetic obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Neuropeptides in learning and memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Different effects of apomorphine on climbing behavior and locomotor activity in three strains of mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Dysregulation of striatal dopamine signaling by amphetamine inhibits feeding by hungry mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Decreased memory for novel object recognition in chronically food-restricted mice is reversed by acute ghrelin administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Importance of D1 and D2 receptors in the dorsal caudate-putamen for the locomotor activity and stereotyped behaviors of preweanling rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Enhancement of feeding suppression by PYY(3-36) in rats with area postrema ablations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The pharmacological and anatomical substrates of the amphetamine response in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Effect of peptide YY3-36 on food intake in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Chronic amphetamine transforms the emotional significance of a novel but not a familiar environment: implications for addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Subtypes of receptors for neuropeptide Y: implications for the targeting of therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Understanding dopamine and reinforcement learning: the dopamine reward prediction error hypothesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Methamphetamine-induced changes in the mice hippocampal neuropeptide Y system: implications for memory impairment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Presidential Address, 1974. The more or less startling effects of weak prestimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The basal ganglia and motor control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Physiological evidence for the involvement of peptide YY in the regulation of energy homeostasis in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Visual working memory capacity and proactive interference.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

A role for dopamine in feeding responses produced by orexigenic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

ACOUSTIC VARIABLES IN THE MODIFICATION OF STARTLE REACTION IN THE RAT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Effects of surgical manipulation of the intestine on peptide YY and its physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Reduction of anxiety after restricted feeding in the rat: implication for eating disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Schizophrenia-relevant behaviours in a genetic mouse model for Y2 deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The role of gut hormones in the regulation of body weight and energy homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The role of peptide YY in appetite regulation and obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Common cellular and molecular mechanisms in obesity and drug addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The roles of GABAB receptors in cortical network activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The ventral pallidum mediates disruption of prepulse inhibition of the acoustic startle response induced by dopamine agonists, but not by NMDA antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Chronic high fat diet consumption impairs sensorimotor gating in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Attenuated peptide YY release in obese subjects is associated with reduced satiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Supraphysiological doses of intravenous PYY 3-36 cause nausea, but no additional reduction in food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Cortical inhibitory neurons and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Construct Validity of the Animal Latent Inhibition Model of Selective Attention Deficits in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Latent inhibition: the effect of nonreinforced pre-exposure to the conditional stimulus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

A theory of attention: Variations in the associability of stimuli with reinforcement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The role of gut hormone peptide YY in energy and glucose homeostasis: twelve years on.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Reduced presynaptic dopamine activity in adolescent dorsal striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Modulation of methylphenidate effects on wheel running and acoustic startle by acute food deprivation in commercially and selectively bred rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Neural basis of psychosis-related behaviour in the infection model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Epidemiology-driven neurodevelopmental animal models of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Chronic administration of the Y2 receptor antagonist, JNJ-31020028, induced anti-depressant like-behaviors in olfactory bulbectomized rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Neurobiology of food intake in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Social approach and repetitive behavior in eleven inbred mouse strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Peptide YY: food for thought.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Dopamine in nucleus accumbens: salience modulation in latent inhibition and overshadowing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Characterization of blood-brain barrier permeability to PYY3-36 in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Stimulation of NPY Y2 receptors by PYY3-36 reveals divergent cardiovascular effects of endogenous NPY in rats on different dietary regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Behavioral animal models of antipsychotic drug actions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Role of dopamine D1 receptors in novelty seeking in adult female Long-Evans rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Effects of PYY[3-36] in rodent models of diabetes and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Plasticity of quantal size in ventral midbrain dopamine neurons: possible implications for the neurochemistry of feeding and reward.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Sex differences in learning and memory following short-term dietary restriction in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Regional and temporal differences in real-time dopamine efflux in the nucleus accumbens during free-choice novelty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Mapping brain circuits of reward and motivation: in the footsteps of Ann Kelley

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Dissecting the diversity of midbrain dopamine neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The mysterious motivational functions of mesolimbic dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The role of habituation in hippocampus-dependent spatial working memory tasks: evidence from GluA1 AMPA receptor subunit knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Enhanced long-term and impaired short-term spatial memory in GluA1 AMPA receptor subunit knockout mice: evidence for a dual-process memory model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

An enteroendocrine full package solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Central nervous system control of food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Prepulse inhibition predicts working memory performance whilst startle habituation predicts spatial reference memory retention in C57BL/6 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Anatomy of the dopamine system in the basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Dopamine, prediction error and associative learning: a model-based account

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Possible mechanisms of circulating PYY-induced satiation in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Administration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The Y2 receptor agonist PYY(3-36) increases the behavioural response to novelty and acute dopaminergic drug challenge in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Characterization of NPY Y2 receptor protein expression in the mouse brain. II. Coexistence with NPY, the Y1 receptor, and other neurotransmitter-related molecules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Lesions of the dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity mediated by nucleus accumbens-ventral pallidal circuitry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Ventral pallidal neurons code incentive motivation: amplification by mesolimbic sensitization and amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Pharmacology and behavioral pharmacology of the mesocortical dopamine system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Getting connected in the dopamine system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

How can drug addiction help us understand obesity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Schizophrenia-relevant behaviors in a genetic mouse model of constitutive Nurr1 deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Postprandial plasma PYY concentrations are associated with increased regional gray matter volume and rCBF declines in caudate nuclei--a combined MRI and H2(15)O PET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Dopaminergic basis of salience dysregulation in psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Dopamine, learning and motivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Inconsistencies in the assessment of food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Food intake, metabolism and homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Central and peripheral regulation of gastric acid secretion by peptide YY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The role of dopamine in conditioning and latent inhibition: what, when, where and how?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

Neuropeptide Y-Y2 receptor knockout mice: influence of genetic background on anxiety-related behaviors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

The nucleus accumbens: gateway for limbic structures to reach the motor system?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2014.12.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YFRNE.2014.12.003

1 reference

1 September 2017

1 reference